Transcriptional profiling of additional p190-CML samples is essential to further understand the pathogenic mechanisms controlling BCR-ABL1+ leukemia phenotype. The gene discussed is CNTNAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.